Is Alzheimer's a disease of the white matter?

Purpose of review Alzheimer's disease has long been primarily considered a disease of gray matter. However, convergent evidence has suggested that white matter abnormalities are also important components of Alzheimer's disease. We undertook a review of the recent findings of Alzheimer's disease related white matter aberrations identified in patients with Alzheimer's disease and using in-vitro and in-vivo models, and discuss the potential causes of white matter damage in Alzheimer's disease. In doing so, we aim to provide a renewed insight into white matter changes in Alzheimer's disease and related dementias. Recent findings Neuroimaging studies have found that patients with preclinical Alzheimer's disease have widespread white matter abnormalities at a stage similar to those reported in Alzheimer's disease, whereas gray matter structures were relatively intact. In addition, demyelination of the white matter is reported to occur prior to the presence of amyloid-&bgr; plaques and neurofibrillary tangles in the presymptomatic stages of Alzheimer's disease. Furthermore, in a mouse model of Alzheimer's disease, axonal disease due to impaired axonal transport was shown to precede and drive downstream production and aggregation of amyloid &bgr; peptides. Summary White matter abnormalities not only represent an early neuropathological event in Alzheimer's disease but may also play an important role in the pathogenesis and diagnosis of Alzheimer's disease.

[1]  R. Escourolle,et al.  Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy , 1985, Annals of neurology.

[2]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[3]  S. M. de la Monte.  Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.

[4]  S. M. de la Monte,et al.  Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.

[5]  A Brun,et al.  White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments , 1990, Histopathology.

[6]  W. Yuh,et al.  Leukoencephalopathy in cerebral amyloid angiopathy: MR imaging in four cases. , 1990, AJNR. American journal of neuroradiology.

[7]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[8]  Albert Hofman,et al.  Cognitive Correlates of Ventricular Enlargement and Cerebral White Matter Lesions on Magnetic Resonance Imaging: The Rotterdam Study , 1994, Stroke.

[9]  A. Hofman,et al.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.

[10]  Khadija Iqbal,et al.  Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[12]  P. Basser,et al.  Diffusion tensor MR imaging of the human brain. , 1996, Radiology.

[13]  Joseph H. Su,et al.  Amyloid deposition in cerebrovascular angiopathy. , 1997, Annals of the New York Academy of Sciences.

[14]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[15]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[16]  R O Weller,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[17]  Elisabet Englund,et al.  Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.

[18]  R. Weller,et al.  Cerebral Amyloid Angiopathy: Accumulation of Aβ in Interstitial Fluid Drainage Pathways in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[19]  R. Weller,et al.  Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. , 2000, Annals of the New York Academy of Sciences.

[20]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[21]  M. Goldberg,et al.  Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes , 2001, The Journal of Neuroscience.

[22]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[23]  Yu-Min Kuo,et al.  Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† , 2002 .

[24]  E. Englund,et al.  Cerebral Amyloid Angiopathy, White Matter Lesions and Alzheimer Encephalopathy – A Histopathological Assessment , 2002, Dementia and Geriatric Cognitive Disorders.

[25]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[26]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[27]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[28]  N. Shahani,et al.  Functions and malfunctions of the tau proteins , 2002, Cellular and Molecular Life Sciences CMLS.

[29]  Douglas Walker,et al.  Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. , 2002, Biochemistry.

[30]  V. Perry,et al.  Axon pathology in neurological disease: a neglected therapeutic target , 2002, Trends in Neurosciences.

[31]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[32]  M. Rossor.  Contribution of cerebral amyloid angiopathy to Alzheimer ’ s disease , 2003 .

[33]  E. Englund,et al.  Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes , 2003, Neuropathology and applied neurobiology.

[34]  T. Beach,et al.  Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease , 2003, Molecular medicine.

[35]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[36]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[37]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[38]  A. Hofman,et al.  Cerebral white matter lesions and the risk of dementia. , 2004, Archives of neurology.

[39]  P. Scheltens,et al.  Measuring progression of cerebral white matter lesions on MRI , 2004, Neurology.

[40]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[41]  J. O'Brien,et al.  Comparison of the pathology of cerebral white matter with post‐mortem magnetic resonance imaging (MRI) in the elderly brain , 2004, Neuropathology and applied neurobiology.

[42]  Xianlin Han,et al.  Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway , 2004, The Journal of Cell Biology.

[43]  Sheng-Kwei Song,et al.  Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition , 2004, Neurobiology of Disease.

[44]  M. Rossor,et al.  NEUROLOGICAL INFECTION AND INFLAMMATION , 2004, Journal of Neurology Neurosurgery & Psychiatry.

[45]  R. Weller,et al.  Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease Pro-CAA position statement , 2004, Neurobiology of Aging.

[46]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[47]  Chi Li,et al.  Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Gong,et al.  Evaluation of bilateral cingulum with tractography in patients with Alzheimer's disease , 2005, Neuroreport.

[49]  Mahendra S Rao,et al.  Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation , 2005, Nature Medicine.

[50]  Alexandra Flemming,et al.  Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.

[51]  D. Rowitch,et al.  Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Love,et al.  Contributors to white matter damage in the frontal lobe in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.

[53]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[54]  Min-Ying Su,et al.  Regional Quantification of White Matter Hyperintensity in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[55]  J. O'Brien,et al.  White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury , 2006, Stroke.

[56]  W. Klein,et al.  Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease , 2006, Journal of Biological Chemistry.

[57]  Jacek Szczygielski,et al.  Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease , 2006, Acta Neuropathologica.

[58]  W. Klein,et al.  Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. , 2006, The Journal of biological chemistry.

[59]  Eric E. Smith,et al.  White Matter Alterations in Cerebral Amyloid Angiopathy Measured by Diffusion Tensor Imaging , 2006, Stroke.

[60]  N. Schuff,et al.  Headache and cerebral venous air embolism , 2007, Neurology.

[61]  V. Hachinski.  The 2005 Thomas Willis Lecture: Stroke and Vascular Cognitive Impairment: A Transdisciplinary, Translational and Transactional Approach , 2007, Stroke.

[62]  J. O'Brien,et al.  Microglial activation in white matter lesions and nonlesional white matter of ageing brains , 2007, Neuropathology and applied neurobiology.

[63]  J. O'Brien,et al.  White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses , 2007, Neuropathology and applied neurobiology.

[64]  Oliver Wirths,et al.  Age-dependent axonal degeneration in an Alzheimer mouse model , 2007, Neurobiology of Aging.

[65]  Hui Zheng,et al.  In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease , 2007, NeuroImage.

[66]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[67]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[68]  Aidong Yuan,et al.  Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice , 2008, The Journal of Neuroscience.

[69]  S. Back,et al.  Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury , 2008, Annals of neurology.

[70]  J. Baron,et al.  Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[71]  C. McCollum,et al.  Paradoxical embolisation and cerebral white matter lesions in dementia. , 2008, The British journal of radiology.

[72]  Eric E. Smith,et al.  Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. , 2008, Archives of neurology.

[73]  Bruce Fischl,et al.  Regional white matter volume differences in nondemented aging and Alzheimer's disease , 2009, NeuroImage.

[74]  J. O'Brien,et al.  Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies , 2010, Acta Neuropathologica.

[75]  W. Bowers,et al.  Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology , 2009, Glia.

[76]  Takahira Yamauchi,et al.  Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: A diffusion tensor tractography study , 2009, Brain Research.

[77]  C. Yasuda,et al.  Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer’s disease , 2009, European journal of neurology.

[78]  J. O'Brien,et al.  Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways , 2009, Stroke.

[79]  Lawrence R. Frank,et al.  Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis , 2009, NeuroImage.

[80]  B. Fischl,et al.  White matter pathology isolates the hippocampal formation in Alzheimer's disease , 2010, Neurobiology of Aging.

[81]  J. Sloane,et al.  Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 , 2010, Proceedings of the National Academy of Sciences.

[82]  Anders H. Andersen,et al.  Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease , 2010, NeuroImage.

[83]  Kai Zhang,et al.  Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.

[84]  Deborah A. Ryan,et al.  Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. , 2010, The American journal of pathology.

[85]  G. Halliday,et al.  Focal demyelination in Alzheimer’s disease and transgenic mouse models , 2010, Acta Neuropathologica.

[86]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[87]  Kuncheng Li,et al.  Voxel-based assessment of gray and white matter volumes in Alzheimer's disease , 2010, Neuroscience Letters.

[88]  In Chan Song,et al.  Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease , 2010, Neurobiology of Aging.

[89]  Vascular cognitive impairment: introduction. , 2004, Stroke.

[90]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[91]  Guy B. Williams,et al.  Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. , 2010, Brain : a journal of neurology.

[92]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[93]  W. Brown,et al.  Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.

[94]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[95]  T. Montine,et al.  White matter lesions defined by diffusion tensor imaging in older adults , 2011, Annals of neurology.

[96]  Klaus P. Ebmeier,et al.  The APOE ɛ4 allele modulates brain white matter integrity in healthy adults , 2011, Molecular Psychiatry.

[97]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[98]  B. Delatour,et al.  Fiber Tracts Anomalies in APPxPS1 Transgenic Mice Modeling Alzheimer's Disease , 2011, Journal of aging research.

[99]  Massimo Filippi,et al.  White matter damage in Alzheimer disease and its relationship to gray matter atrophy. , 2011, Radiology.

[100]  K. Hwang,et al.  Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer’s disease , 2011, Journal of Clinical Neuroscience.

[101]  J. Molinuevo,et al.  Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance , 2012, Neurobiology of Aging.

[102]  Simone Reppermund,et al.  Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. , 2012, Journal of Alzheimer's disease : JAD.

[103]  Lin Zhuang,et al.  Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI , 2012, Neurology.

[104]  D. Y. Lee,et al.  Sub-Regional Hippocampal Injury is Associated with Fornix Degeneration in Alzheimer’s Disease , 2012, Front. Ag. Neurosci..

[105]  Takayuki Itoh,et al.  Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro , 2012, Neurobiology of Aging.

[106]  C Caltagirone,et al.  White matter damage along the uncinate fasciculus contributes to cognitive decline in AD and DLB. , 2012, Current Alzheimer research.

[107]  Anders M. Fjell,et al.  White matter imaging changes in subjective and mild cognitive impairment , 2012, Alzheimer's & Dementia.

[108]  Igor O. Korolev,et al.  Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: A DTI/FDG‐PET Study , 2012, Human brain mapping.

[109]  M. Götz,et al.  Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men , 2013, Glia.

[110]  L. Mucke,et al.  Amyloid-beta / Fyn – Induced Synaptic , Network , and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer ’ s Disease , 2015 .